GeneDx Holdings (WGS) Acquisitions (2023 - 2025)

GeneDx Holdings (WGS) posted quarterly Acquisitions of -$33.2 million for Q4 2025, down 173.34% quarter-over-quarter from -$12.1 million in Q4 2023.

GeneDx Holdings (WGS) Acquisitions (2023 - 2025) Analysis & Trends

GeneDx Holdings (WGS) has reported Acquisitions for 2 consecutive years, with -$33.2 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Acquisitions changed N/A year-over-year to -$33.2 million; the TTM figure through Dec 2025 stood at -$33.2 million (down 173.34% YoY), while the FY2022 annual figure was $127.0 million, changed N/A from the prior year.
  • Acquisitions slipped to -$33.2 million in Q4 2025 per WGS's latest filing, from -$12.1 million in the prior quarter.
  • Across five years, Acquisitions topped out at -$12.1 million in Q4 2023 and bottomed at -$33.2 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn 163.00 Mn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn 2.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -
10 GeneDx Holdings 2.08 Bn 1.94 Bn 78.24 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.20 Mn
Dec 31, 2023 -12.14 Mn